Shalin Shakya, MD
Hospitalist · Cypress, TXNPI 1548573173
Payments from drug & device makers
Across 69 payments — averaging $41.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$1K
- AstraZeneca$686
- Johnson & Johnson$317
- La Jolla Pharmaceutical Company$212
- Madrigal Pharmaceuticals$136
- BETA Bionics, Inc.$132
- plus $355 from 8 others
What the payments were for
- Food & beverage$2,894100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 16 | $1,056 |
| AstraZeneca(2 entities) | 15 | $686 |
| Johnson & Johnson | 16 | $317 |
| La Jolla Pharmaceutical Company | 2 | $212 |
| Madrigal Pharmaceuticals | 1 | $136 |
| BETA Bionics, Inc. | 1 | $132 |
| Novartis | 7 | $123 |
| Melinta Therapeutics, LLC | 1 | $55 |
| Vifor Pharma, Inc. | 2 | $47 |
| AbbVie | 3 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$866
- iLet Bionic Pancreas$395
- LOKELMA$250
- ANDEXXA$249
- REZDIFFRA$136
- iLet Insulin Infusion Kit Inset$132
- iLet Insulin Infusion Kit Contact Detach$132
- Xerava$118
How this compares
$2,894 in reported general payments places this provider in the 95th percentile of 1,284 hospitalist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $8,750 |
| Pantoprazole Sodium | 22 | $373 |
| Cefdinir | 36 | $293 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $164 |
| Metoprolol Succinate | 25 | $163 |
| Amiodarone Hcl | 11 | $108 |
| Methylprednisolone | 12 | $89 |
| Atorvastatin Calcium | 19 | $86 |
| Lisinopril | 14 | $62 |
| ClopidogrelClopidogrel Bisulfate | 12 | $58 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $58 |
| Tamsulosin Hcl | 11 | $42 |
| Furosemide | 17 | $35 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Cypress
- Sarah SmileyAustin$19.9M
- Ingela Danielsson-SandenMcAllen$5.9M
- Nitendra AgarwalSan Antonio$3.5M
- James TaylorBrownwood$2.8M
- Bingnan ZhangHouston$524K
- Sayyed JaffriStafford$434K
- Jan KemnadeHouston$360K
- Kenechukwu EnekebeCorpus Christi$311K
- Ryan NealHouston$154K
- Eduardo UribeSan Antonio$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.